deguelin has been researched along with piroxicam in 1 studies
| Studies (deguelin) | Trials (deguelin) | Recent Studies (post-2010) (deguelin) | Studies (piroxicam) | Trials (piroxicam) | Recent Studies (post-2010) (piroxicam) |
|---|---|---|---|---|---|
| 182 | 0 | 115 | 3,084 | 796 | 704 |
| Protein | Taxonomy | deguelin (IC50) | piroxicam (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.3043 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.1 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosmeder, JW; Mehta, RG; Murillo, G; Pezzuto, JM | 1 |
1 other study(ies) available for deguelin and piroxicam
| Article | Year |
|---|---|
Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; beta-N-Acetylhexosaminidases; Colon; Colonic Neoplasms; Female; Intestinal Mucosa; Mice; Molecular Structure; Piroxicam; Precancerous Conditions; Rotenone | 2003 |